These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 3820126)

  • 21. Effects of amphetamine on electroshock responses in developing rats.
    Vernadakis A; Robb D
    Dev Psychobiol; 1974 Jan; 7(1):89-95. PubMed ID: 4812273
    [No Abstract]   [Full Text] [Related]  

  • 22. The effects of low-dose combinations of D-amphetamine and cocaine on experimentally induced conflict in the rat.
    Geller I; Hartmann RJ; Blum K
    Curr Ther Res Clin Exp; 1972 Apr; 14(4):220-4. PubMed ID: 4623601
    [No Abstract]   [Full Text] [Related]  

  • 23. Effect of intraperitoneally injected lysine vasopressin on noradrenaline turnover in certain brain regions of the rat.
    Szadowska A; Szmigielska H; Szmigielski A
    Acta Physiol Pol; 1982; 33(5-6):447-53. PubMed ID: 6821183
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dose dependent modification of codeine analgesia by d-amphetamine in albino rats.
    Ahmed SS; Abraham GJ; Ansari MY
    Arch Int Pharmacodyn Ther; 1970 Apr; 184(2):240-4. PubMed ID: 5453228
    [No Abstract]   [Full Text] [Related]  

  • 25. Distribution and occurrence of amphetamine and p-hydroxyamphetamine in tissues of the rat after injection of d-amphetamine sulfate.
    Danielson TJ; Boulton AA
    Eur J Pharmacol; 1976 Jun; 37(2):257-64. PubMed ID: 954809
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Concentration of amphetamine isomers in brain and heart of adult and developing mice.
    Alhava E
    Acta Pharmacol Toxicol (Copenh); 1976 Apr; 38(4):336-43. PubMed ID: 946732
    [No Abstract]   [Full Text] [Related]  

  • 27. Tolerance and cross-tolerance to mescaline and amphetamine as a function of central and peripheral administration.
    Sparber SB; Tilson HA
    Psychopharmacologia; 1972; 23(3):220-30. PubMed ID: 5067530
    [No Abstract]   [Full Text] [Related]  

  • 28. Incorporation of D-amphetamine into pigmented guinea-pig hair.
    Harrison WH; Gray RM; Solomon LM
    Br J Dermatol; 1974 Oct; 91(4):415-8. PubMed ID: 4425620
    [No Abstract]   [Full Text] [Related]  

  • 29. A dehydrogenase system to demonstrate oxidation of amphetamine and related compounds by rat brain homogenate.
    Ghosh SK; Guha SR
    Indian J Physiol Pharmacol; 1977; 21(2):137-40. PubMed ID: 885599
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Morphological changes in the rat brain after intracardiac and intraperitoneal administration of quinolinic acid].
    Beskid M; Markiewicz D
    Neuropatol Pol; 1988; 26(1):61-8. PubMed ID: 2976127
    [No Abstract]   [Full Text] [Related]  

  • 31. Effect of reserpine on accumulation and removal of d-amphetamine- 3 H.
    Stolk JM; Rech RH
    Biochem Pharmacol; 1969 Oct; 18(10):2786-8. PubMed ID: 5404008
    [No Abstract]   [Full Text] [Related]  

  • 32. Amphetamine in rat brain after intraperitoneal injection of N-alkylated analogues.
    Nazarali AJ; Baker GB; Coutts RT; Pasutto FM
    Prog Neuropsychopharmacol Biol Psychiatry; 1983; 7(4-6):813-6. PubMed ID: 6686713
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inability of rat brain homogenate to oxidize amphetamine.
    Maickel RP; Harrison SD
    Biochem Pharmacol; 1974 Mar; 23(6):1146-7. PubMed ID: 4824914
    [No Abstract]   [Full Text] [Related]  

  • 34. A comparison of the kinetics of d- and l-amphetamine in the brain of isolated and aggregated rats.
    Lokiec F; Rapin JR; Jacquot C; Cohen Y
    Psychopharmacology (Berl); 1978 Jun; 58(1):73-7. PubMed ID: 97723
    [No Abstract]   [Full Text] [Related]  

  • 35. Regional brain distribution of alpha-amphetamine in lead-exposed rats.
    Zenick H; Lasley SM; Greenland R; Caruso V; Succop P; Price D; Michaelson IA
    Toxicol Appl Pharmacol; 1982 Jun; 64(1):52-63. PubMed ID: 7112584
    [No Abstract]   [Full Text] [Related]  

  • 36. Differences in the availability of d- and l-enantiomers after administration of racemic amphetamine to rats.
    Jori A; Caccia S; de Ponte P
    Xenobiotica; 1978 Oct; 8(10):589-95. PubMed ID: 716470
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The influence of neuroleptics on amphetamine metabolism in the rat and guinea-pig.
    Yokel RA
    J Pharm Pharmacol; 1978 Nov; 30(11):719-21. PubMed ID: 31438
    [No Abstract]   [Full Text] [Related]  

  • 38. The conversion in vivo of D-amphetamine to (+)-p-hydroxynorephedrine.
    Goldstein M; Anagnoste B
    Biochim Biophys Acta; 1965 Aug; 107(1):166-8. PubMed ID: 5857361
    [No Abstract]   [Full Text] [Related]  

  • 39. Factors influencing the plasma levels of amphetamine and its metabolites in catheterized rats.
    Pashko S; Vogel WH
    Biochem Pharmacol; 1980 Feb; 29(2):221-5. PubMed ID: 7362635
    [No Abstract]   [Full Text] [Related]  

  • 40. Amphetamine actions in dorsolateral tegmental rats: hypodipsia, anorexia, and central nervous system permeation to [14C] amphetamine.
    Wellman PJ; Clark DE; Rogers JK; Thomas JC
    Behav Neural Biol; 1982 May; 35(1):64-9. PubMed ID: 7126099
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.